Home / Research Articles Hub / Effectiveness of mRNA BNT162b2 COVID-19 vaccine up...
🧬 Medicine & Biology OpenAlex

Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study

📅 Published: October 1, 2021 👤 Sara Y. Tartof, Jeff Slezak, Heidi Fischer et al. 📖 The Lancet 📊 1,277 citations
AI-Generated Summary

This research explores Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 mont..., contributing new insights to the field of Medicine & Biology.

⚡ This is an original paraphrased summary — not copied from the abstract. Full paper available at the source link below.

Key Findings
  • 1 Research demonstrates significant advances in patient outcome data
  • 2 Study provides new evidence regarding clinical efficacy results
  • 3 Findings open new directions for biological mechanism insights
Why It Matters

Understanding this could lead to better treatments, improved diagnostics, or a deeper grasp of how the human body works — benefiting patient care globally.

This summary is based on publicly available metadata and abstract. For the full research paper, visit the original source:

Read Full Paper at OpenAlex
More Medicine & Biology Papers ← Back to Hub 📚 Learning Hub